- Home
- DOCS vs RCUS Comparison
DOCS vs RCUS Comparison
Compare DOCS & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCS | RCUS |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DOCS | RCUS |
|---|---|---|
| Price | $25.30 | $30.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 10 |
| Target Price | ★ $45.50 | $31.90 |
| AVG Volume (30 Days) | ★ 6.6M | 1.2M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $644,863,000.00 | $247,000,000.00 |
| Revenue This Year | $15.08 | N/A |
| Revenue Next Year | $8.83 | $45.62 |
| P/E Ratio | $194.85 | ★ N/A |
| Revenue Growth | ★ 13.05 | N/A |
| 52 Week Low | $17.15 | $10.07 |
| 52 Week High | $76.51 | $31.74 |
Technical Indicators
Market Signals| Indicator | DOCS | RCUS |
|---|---|---|
| Relative Strength Index (RSI) | 57.15 | 59.77 |
| Support Level | $23.46 | $25.94 |
| Resistance Level | $26.21 | $31.41 |
| Average True Range (ATR) | 2.18 | 1.22 |
| MACD | 0.06 | 0.14 |
| Stochastic Oscillator | 27.14 | 75.44 |
Price Performance
Historical ComparisonAbout DOCS Doximity Inc.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.